Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep;82(3):1613-1627.
doi: 10.1007/s12013-024-01317-6. Epub 2024 May 28.

Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths

Affiliations
Review

Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths

Ahmed Hjazi et al. Cell Biochem Biophys. 2024 Sep.

Abstract

The advancement of novel technologies, coupled with bioinformatics, has led to the discovery of additional genes, such as long noncoding RNAs (lncRNAs), that are associated with drug resistance. LncRNAs are composed of over 200 nucleotides and do not possess any protein coding function. These lncRNAs exhibit lower conservation across species, are typically expressed at low levels, and often display high specificity towards specific tissues and developmental stages. The LncRNA MALAT1 plays crucial regulatory roles in various aspects of genome function, encompassing gene transcription, splicing, and epigenetics. Additionally, it is involved in biological processes related to the cell cycle, cell differentiation, development, and pluripotency. Recently, MALAT1 has emerged as a novel mechanism contributing to drug resistance or sensitivity, attracting significant attention in the field of cancer research. This review aims to explore the mechanisms through which MALAT1 confers resistance to chemotherapy and radiotherapy in cancer cells.

Keywords: Cancer; Chemo-radiotherapy; LncRNA; MALAT1; Resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Petit, C., Lacas, B., Pignon, J. P., Le, Q. T., Grégoire, V., & Grau, C. et al.(2021). Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. The Lancet Oncology, 22, 727–736. - PubMed - DOI
    1. Kokka, F., Bryant, A., Olaitan, A., Brockbank, E., Powell, M., & Oram, D. (2022). Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. The Cochrane Database of Systematic Reviews, 8, Cd010260 - PubMed
    1. Hickey, B. E., Francis, D. P., Lehman, M. (2013). Sequencing of chemotherapy and radiotherapy for early breast cancer. Cochrane Database Systematic Reviews. 30, Cd005212.
    1. Haussmann, J., Tamaskovics, B., Bölke, E., Djiepmo-Njanang, F. J., Kammers, K., & Corradini, S., et al. (2019). Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft, 195, 1041–1049. - DOI
    1. Najafi, S. (2022). Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials. International Journal of Biological Macromolecules, 206, 939–953. - PubMed - DOI

MeSH terms

Substances

LinkOut - more resources